QuLF-CT positivity

Biomarker

1 paper mentions it1 finding

1 new paper in 30 daysSee all 1 papers on QuLF-CT positivity

“Among attenuation-defined normal individuals, QuLF-CT positivity was consistently associated with increased MACE risk across all HU thresholds.”
AI-Derived Liver Fat Identifies Subclinical Cardiovascular Risk Missed by Conventional CT AttenuationAHA Scientific Sessions 2026 abstract2026doi:10.1161/circ.154.suppl_1.13365

Associations

1

Major adverse cardiovascular events

upin humans1HR 1.21

1 study
  1. QuLF-CT positivity is associated with major adverse cardiovascular events in humans (HRs 1.21 (95% CI 1.08-1.36) to 1.69 (95% CI 1.45-1.97) across attenuation thresholds; all p < 0.01).

    “Among attenuation-defined normal individuals, QuLF-CT positivity was consistently associated with increased MACE risk across all HU thresholds.”

    HumansNormal hepatic CT attenuation and QuLF-CT liver fat fraction >5%, compared with normal attenuation and QuLF-CT negativityliverMedian follow-up 4.03 years

    AI liver fat measure linked to overlooked cardiovascular risk

    AHA Scientific Sessions 2026 abstract

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 11 paper in 12 months
AHA Scientific Sessions 2026 Abstract

AI liver fat measure linked to overlooked cardiovascular risk

People flagged only by AI had cardiovascular-event hazard ratios of 1.21–1.69 versus those normal on both measures; ratios above one indicate higher risk.People flagged only by AI had cardiovascular-event hazard ratios of 1.21–1.69 versus those normal on both measures; ratios above one indicate higher risk.

Cohort · 43,340 peopleBiomarkers